Form 8-K - Current report:
SEC Accession No. 0001628280-25-023129
Filing Date
2025-05-07
Accepted
2025-05-07 16:01:53
Documents
36
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20250507.htm   iXBRL 8-K 27734
2 EX-99.1 ex991pressrelease-q12025.htm EX-99.1 131954
3 EX-99.2 ex992earningspresentatio.htm EX-99.2 25958
7 cdxc-20250507_g1.jpg GRAPHIC 143741
8 ex992earningspresentatio001.jpg GRAPHIC 47953
9 ex992earningspresentatio002.jpg GRAPHIC 222671
10 ex992earningspresentatio003.jpg GRAPHIC 168212
11 ex992earningspresentatio004.jpg GRAPHIC 89836
12 ex992earningspresentatio005.jpg GRAPHIC 73532
13 ex992earningspresentatio006.jpg GRAPHIC 115204
14 ex992earningspresentatio007.jpg GRAPHIC 85588
15 ex992earningspresentatio008.jpg GRAPHIC 102755
16 ex992earningspresentatio009.jpg GRAPHIC 161215
17 ex992earningspresentatio010.jpg GRAPHIC 127593
18 ex992earningspresentatio011.jpg GRAPHIC 66792
19 ex992earningspresentatio012.jpg GRAPHIC 141274
20 ex992earningspresentatio013.jpg GRAPHIC 135342
21 ex992earningspresentatio014.jpg GRAPHIC 179681
22 ex992earningspresentatio015.jpg GRAPHIC 60460
23 ex992earningspresentatio016.jpg GRAPHIC 140518
24 ex992earningspresentatio017.jpg GRAPHIC 97469
25 ex992earningspresentatio018.jpg GRAPHIC 69224
26 niagen-biosciencexlogoxhora.jpg GRAPHIC 143741
27 niagen-biosciencexlogoxicona.jpg GRAPHIC 48828
  Complete submission text file 0001628280-25-023129.txt   3801757

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20250507.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20250507_lab.xml EX-101.LAB 22578
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20250507_pre.xml EX-101.PRE 13042
38 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20250507_htm.xml XML 2826
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
Niagen Bioscience, Inc. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 25921120
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)